Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2016 / Cilt: 50 - Sayı: 2

Tiroidin foliküler karsinom ve adenomlarının ayırımında galektin-3 ve CD44v6 ekspresyonunun rolü

Role of Galectin-3 and CD44v6 Expression in the Differentiation of the Follicular Carcinoma and Adenoma of the Thyroid

Pages
131–136
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Then sections were investigated under light microscope and labeled as no staining (-), focal weak staining (+), moderately intense staining (++), intense staining (+++).Results: Galectin-3 expression was significant in the differentiation of the follicular carcinoma and adenoma (p<0.05), whereas CD44v6 was not a potential marker in the differentiation of the follicular carcinoma and adenoma (p>0.05).Conclusion: Galectin-3 was determined as a potential marker in the diagnosis of follicular carcinoma but CD44v6 expression was not a diagnostic value in the differentiation of follicular carcinoma and adenoma

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The role of the galectin-3 and CD44v6 expression in the differentiation of the thyroid follicular carcinoma and follicular adenoma were investigated in many preoperative cytologic samples and significant results were achieved.
📊
Key Findings & Data:In this study, we investigated galectin-3 and CD44v6 as potential supportive markers of histopathologic diagnosis in the differentiation of follicular carcinoma and adenoma of thyroid in conventional tissue sections.Material and Method: A total of 60 thyroidectomy specimens from Kartal Dr.
💡
Conclusion & Impact:Then sections were investigated under light microscope and labeled as no staining (-), focal weak staining (+), moderately intense staining (++), intense staining (+++).Results: Galectin-3 expression was significant in the differentiation of the follicular carcinoma and adenoma (p<0.05), whereas CD44v6 was not a potential marker in the differentiation of the follicular carcinoma and adenoma (p>0.05).Conclusion: Galectin-3 was determined as a potential marker in the diagnosis of follicular carcinoma but CD44v6 expression was not a diagnostic value in the differentiation of follicular carcinoma and adenoma
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The role of the galectin-3 and CD44v6 expression in the differentiation of the thyroid follicular carcinoma and follicular adenoma were investigated in many preoperative cytologic samples and significant results were achieved. In this study, we investigated galectin-3 and CD44v6 as potential supportive markers of histopathologic diagnosis in the differentiation of follicular carcinoma and adenoma of thyroid in conventional tissue sections.Material and Method: A total of 60 thyroidectomy specimens from Kartal Dr. Lütfi Kırdar Training and Research Hospital and Istanbul University Cerrahpasa Medical Faculty Pathology Department were investigated retrospectively. Twenty cases of the 60 thyroidectomy specimens were diagnosed as follicular carcinoma and 40 cases were diagnosed as follicular adenoma. Sections taken adjacent to the capsule of the nodule were stained immunohistochemically by HRP-AEC method for galectin-3 and CD44v6 antibody. Then sections were investigated under light microscope and labeled as no staining (-), focal weak staining (+), moderately intense staining (++), intense staining (+++).Results: Galectin-3 expression was significant in the differentiation of the follicular carcinoma and adenoma (p<0.05), whereas CD44v6 was not a potential marker in the differentiation of the follicular carcinoma and adenoma (p>0.05).Conclusion: Galectin-3 was determined as a potential marker in the diagnosis of follicular carcinoma but CD44v6 expression was not a diagnostic value in the differentiation of follicular carcinoma and adenoma

Özet

Amaç: Foliküler karsinom ve adenomların ayrımında galektin-3 ve CD44v6 ekspresyonu birçok çalışmada sitolojik preperatlarda preoperatif olarak incelenmiş ve anlamlı sonuçlar elde edilmiştir. Bu çalışmada tiroid foliküler karsinom ve adenomlarının ayırımında galektin-3 ve CD44v6 ekspresyonunun patolojik tanıya yardımcı olup olamayacağı araştırıldı.Gereç ve Yöntem: Bu çalışmada Kartal Dr. Lütfi Kırdar Eğitim ve Araştırma Hastanesi Patoloji Kliniğinde 1992-2002 yılları arasında ve İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Ana Bilim Dalında 2001 yılına ait olgular olmak üzere toplam 60 adet foliküler adenom ve karsinom olgusu incelenmiştir. Bunların 20'si foliküler karsinom, 40 tanesi foliküler adenom olgusudur. Bu olguların galektin-3 ve CD44v6 ekspresyonu immunohistokimyasal olarak incelenmiştir.Her olgudan kapsüle bitişik alanlardan alınan kesitlere galektin-3 ve CD44v6 antikorları için HRP-AEC yöntemiyle immunohistokimyasal boyama uygulandı ve kesitler ışık mikroskobunda boyanma yok (-), fokal zayıf boyanma (+), orta yoğunlukta boyanma (++), kuvvetli boyanma (+++) olarak değerlendirildi.Bulgular: Immunohistokimyasal inceleme sonucunda foliküler karsinom ve adenom olgularının ayırımında galektin-3 ekspresyonunun anlamlı olduğu saptanmıştır (p 0.05).Sonuç: Tiroidin foliküler karsinom ve adenomlarının ayırımında galektin-3'ün tanıyı destekleyici potansiyel bir antikor olduğu, CD44v6'nın ise bu ayırımda bir önemi olmadığı saptanmıştır

🔖

Cite This Article

DAŞ, T., KARADAYI, N., YAVUZER, D., TOPAL, C. S. (2016). Tiroidin foliküler karsinom ve adenomlarının ayırımında galektin-3 ve CD44v6 ekspresyonunun rolü. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 50 - Sayı: 2, 131–136. https://ajindex.com/articles/399604

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Orlandi F, Saggiorato E, Pivano G, Puligheddu B, Termine A, Cappia S, et al. Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res 1998; 58: 3015-20.
  2. Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J, Hattori K, et al. Expression of galectin-3 in fine needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer 1999; 85: 2475-84. [CrossRef] Saggiorato E, Cappia S, De Giuli P, Mussa A, Pancani G, Caraci P, et al. Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J Clin Endocrinol Metab 2001; 86: 5152-8. [CrossRef] Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, et al. Application of a immunodiagnostic method for improving preoperative diagnosis of noduler thyroid lesions. Lancet 2001; 357: 1644-50. [CrossRef] Gasbarri A, Martegani MP, Del Prete F, Lucante T, Natali PG, Bartolazzi A. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol 1999; 17: 3494-502.
  3. Fernandez PL, Merino MJ, Gomez M, Campo E, Medina T, Castronovo V, et al. Galectin-3 and laminin expression in neoplastic and nonneoplastic thyroid tissue. J Pathol 1997; 181: 80-6. [CrossRef] Kawachi K, Matsushita Y, Yonezawa S, Nakano S, Shirao K, Natsugoe S, et al. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Hum Pathol 2000; 31: 428-33. [CrossRef] Cvejic D, Savin S, Golubovic S, Paunovic I, Tatic S, Havelka M. Galectin-3 and carcinoembryogenic antigen expression in medullary thyroid carcinoma:possible relation to tumor progression. Histopathology 2000; 37: 530-5. [CrossRef] Nasser SM, Pitman MB, Pilch BZ, Faquin WC. Fine needle aspiration biopsy papillary thyroid carcinoma:diagnostic utility of cytokeratin 19 immunostaining. Cancer 2000; 90: 307-11. [CrossRef] Kurozumi K, Nakao K, Nishida T, Nakahara M, Ogino N, Tsujimoto M. Significance of biologic aggresiveness and proliferating activity in papillary thyroid carcinoma. World J Surg 1998; 22: 1237-42. [CrossRef] Rosahl SK, Erpenbeck V, Vorkapic P, Samii M. Solitary follicular thyroid carcinoma of skull base and its differentiation from ectopic adenoma-review, use of galectin-3 and report of a new case. Clin Neurol Neurosurg 2000; 102: 149-55. [CrossRef] Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol 2001; 14: 338-42. [CrossRef] Zhang L, Krausz